American Journal of Cardiology
Volume 106, Issue 6 , Pages 774-779 , 15 September 2010

Effect of Coronary Target Lesion Revascularization on Late Cardiac Events After Insertion of Sirolimus-Eluting or Bare Metal Stents

  • Victor Novack, MD, PhD

      Affiliations

    • Harvard Clinical Research Institute, Boston, Massachusetts
    • Dr. Novack and Dr. Nguyen contributed equally to this article.
    • ,
  • Michael C. Nguyen, MBBS

      Affiliations

    • Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
    • Dr. Novack and Dr. Nguyen contributed equally to this article.
    • ,
  • Meredith Rooney, MD

      Affiliations

    • Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
    • ,
  • Riya Chacko, MD

      Affiliations

    • Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
    • ,
  • Lena Novack, PhD

      Affiliations

    • Harvard Clinical Research Institute, Boston, Massachusetts
    • ,
  • Michael Pencina, PhD

      Affiliations

    • Harvard Clinical Research Institute, Boston, Massachusetts
    • ,
  • Patricia Apruzzese, MA

      Affiliations

    • Harvard Clinical Research Institute, Boston, Massachusetts
    • ,
  • Laura Mauri, MD, MSc

      Affiliations

    • Harvard Clinical Research Institute, Boston, Massachusetts
    • ,
  • Sidney A. Cohen, MD, PhD

      Affiliations

    • Cordis Inc., Warren, New Jersey; Division of Cardiology, Hospital of University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Jeffrey Moses, MD

      Affiliations

    • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York
    • ,
  • Martin B. Leon, MD

      Affiliations

    • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York
    • ,
  • Donald E. Cutlip, MD

      Affiliations

    • Harvard Clinical Research Institute, Boston, Massachusetts
    • Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationCorresponding author: Tel: (617) 632-7455; fax: (617) 632-7460

Received 14 March 2010 ,Accepted 26 April 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Funding for the conduct of the Sirolimus-Eluting Stent in De Novo Native Coronary Lesions (SIRIUS) trial, including management and analysis of the 5-year follow-up was provided by the Cordis Corporation, Warren, New Jersey, through a services contract with the Harvard Clinical Research Institute (Boston, Massachusetts). Funding for the statistical analysis of this substudy was provided by Cordis Corporation (Warren, New Jersey) through a research grant to the Harvard Clinical Research Institute (Boston, Massachusetts).

 Dr. Mauri has received honoraria from Abbott Vascular, Redwood City, California, Boston Scientific, Natick, Massachusetts, Cordis Corporation, Warren, New Jersey, and Medtronic Vascular, Santa Rosa, California, and either consulting fees or honoraria from Cordis, Warren, New Jersey, Boston Scientific, Natick, Massachusetts, Medtronic, Santa Rosa, California, and Abbott Vascular, Redwood City, California. Dr. Cohen is a full-time employee of Cordis Corporation, Warren, New Jersey. Dr. Moses has received consulting fees from Johnson & Johnson, Warren, New Jersey. Dr. Leon has received either consulting fees or honoraria from Cordis (Warren, New Jersey), Boston Scientific (Natick, Massachusetts), Medtronic (Santa Rosa, California), and Abbott Vascular (Redwood City, California).

PII: S0002-9149(10)01035-0

doi: 10.1016/j.amjcard.2010.04.039

American Journal of Cardiology
Volume 106, Issue 6 , Pages 774-779 , 15 September 2010

Article Tools

* Image Usage & Resolution